Viewing Study NCT02845856


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-06 @ 8:52 AM
Study NCT ID: NCT02845856
Status: COMPLETED
Last Update Posted: 2019-09-12
First Post: 2016-07-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer
Sponsor: Fuda Cancer Hospital, Guangzhou
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module